Fig 6.BCAT1 knockdown affects tumor growth in vivo. (a,b) Cross-sections of tumors 28 d after intracranial injection of U-87MG glioblastoma cells into CD-1 nu/nu mice. H&E staining is shown for mice injected with control nontargeting shRNA–transduced (a) or BCAT1 shRNAI–transduced (b) cells. Scale bars, 1 mm.
|
- Tönjes M, Barbus S, Park YJ, Wang W, Schlotter M, Lindroth AM, Pleier SV, Bai AH, Karra D, Piro RM, Felsberg J, Addington A, Lemke D, Weibrecht I, Hovestadt V, Rolli CG, Campos B, Turcan S, Sturm D, Witt H, Chan TA, Herold-Mende C, Kemkemer R, König R, Schmidt K, Hull WE, Pfister SM, Jugold M, Hutson SM, Plass C, Okun JG, Reifenberger G, Lichter P, Radlwimmer B
- Nat Med. 2013 Jul;19(7):901-8.
|